Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Pivotal Findings for a High-Sensitivity Cardiac Troponin Assay: Results of the HIGH-US Study.

Christenson RH, Duh SH, Apple FA, Nowak R, Peacock WF, Limkakeng AT Jr, Bostanian Z, Mohammad A, McCord J, deFilippi CR.

Clin Biochem. 2019 Oct 26. pii: S0009-9120(19)30972-5. doi: 10.1016/j.clinbiochem.2019.10.013. [Epub ahead of print]

PMID:
31669511
2.

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.

Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, Christenson R, Seliger SL, Soliman EZ, Deo R, Ky B, Feldman HI, Kusek JW, deFilippi CR, Wolf MS, Shafi T, Go AS, Bansal N; CRIC Study Investigators.

J Am Heart Assoc. 2019 Aug 6;8(15):e012200. doi: 10.1161/JAHA.119.012200. Epub 2019 Aug 5.

3.

Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I.

Sandoval Y, Nowak R, deFilippi CR, Christenson RH, Peacock WF, McCord J, Limkakeng AT, Sexter A, Apple FS.

J Am Coll Cardiol. 2019 Jul 23;74(3):271-282. doi: 10.1016/j.jacc.2019.05.058.

PMID:
31319909
4.

Relation of Dietary Sodium Intake With Subclinical Markers of Cardiovascular Disease (from MESA).

Kapoor K, Fashanu O, Post WS, Lutsey PL, Michos ED, deFilippi CR, McEvoy JW.

Am J Cardiol. 2019 Aug 15;124(4):636-643. doi: 10.1016/j.amjcard.2019.05.014. Epub 2019 May 29.

PMID:
31300201
5.

Trends in Blood Pressure and High-Sensitivity Cardiac Troponin-T With Cardiovascular Disease: The Cardiovascular Health Study.

Tehrani DM, Fan W, Nambi V, Gardin J, Hirsch CH, Amsterdam E, deFilippi CR, Polonsky T, Wong ND.

Am J Hypertens. 2019 Sep 24;32(10):1013-1020. doi: 10.1093/ajh/hpz102.

PMID:
31232455
6.

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

House AA, Wanner C, Sarnak MJ, Piña IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA; Conference Participants.

Kidney Int. 2019 Jun;95(6):1304-1317. doi: 10.1016/j.kint.2019.02.022. Epub 2019 Apr 30.

7.

Standardized Team-Based Care for Cardiogenic Shock.

Tehrani BN, Truesdell AG, Sherwood MW, Desai S, Tran HA, Epps KC, Singh R, Psotka M, Shah P, Cooper LB, Rosner C, Raja A, Barnett SD, Saulino P, deFilippi CR, Gurbel PA, Murphy CE, O'Connor CM.

J Am Coll Cardiol. 2019 Apr 9;73(13):1659-1669. doi: 10.1016/j.jacc.2018.12.084. Erratum in: J Am Coll Cardiol. 2019 Jul 23;74(3):481.

8.

NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure.

Whitman IR, Vittinghoff E, DeFilippi CR, Gottdiener JS, Alonso A, Psaty BM, Heckbert SR, Hoogeveen RC, Arking DE, Selvin E, Chen LY, Dewland TA, Marcus GM.

J Am Heart Assoc. 2019 Apr 2;8(7):e010868. doi: 10.1161/JAHA.118.010868.

9.

Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study.

Christenson RH, Peacock WF, Apple FS, Limkakeng AT Jr, Nowak RM, McCord J, deFilippi CR.

Contemp Clin Trials Commun. 2019 Feb 15;14:100337. doi: 10.1016/j.conctc.2019.100337. eCollection 2019 Jun.

10.

Symptoms Predictive of Acute Myocardial Infarction in the Troponin Era: Analysis From the TRAPID-AMI Study.

McCord J, Aurora L, Lindahl B, Giannitsis E, Calle-Muller C, Nowak R, Body R, Christ M, deFilippi CR, Christenson RH, Jacobsen G, Alquezar A, Panteghini M, Melki D, Plebani M, Verschuren F, French J, Bendig G, Weiser S, Mueller C; TRAPID-AMI Investigators.

Crit Pathw Cardiol. 2019 Mar;18(1):10-15. doi: 10.1097/HPC.0000000000000163.

PMID:
30747759
11.

Myocardial Dysfunction With Contemporary Management of HIV: Prevalence, Pathophysiology, and Opportunities for Prevention.

deFilippi CR, Grinspoon SK.

JACC Heart Fail. 2019 Feb;7(2):109-111. doi: 10.1016/j.jchf.2018.12.004. No abstract available.

PMID:
30704602
13.

Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction.

Mueller-Hennessen M, Lindahl B, Giannitsis E, Vafaie M, Biener M, Haushofer AC, Seier J, Christ M, Alquézar-Arbé A, deFilippi CR, McCord J, Body R, Panteghini M, Jernberg T, Plebani M, Verschuren F, French JK, Christenson RH, Dinkel C, Katus HA, Mueller C.

Int J Cardiol. 2019 Feb 1;276:261-267. doi: 10.1016/j.ijcard.2018.10.084. Epub 2018 Oct 26.

PMID:
30404726
14.

Sex Hormones and Change in N-Terminal Pro-B-Type Natriuretic Peptide Levels: The Multi-Ethnic Study of Atherosclerosis.

Ying W, Zhao D, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, Sharma K, Shah SJ, Heckbert SR, Lima JA, deFilippi CR, Budoff MJ, Post WS, Michos ED.

J Clin Endocrinol Metab. 2018 Nov 1;103(11):4304-4314. doi: 10.1210/jc.2018-01437.

15.

Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction.

McCord J, Newby LK, deFilippi CR.

Circulation. 2018 Jul 17;138(3):316-318. doi: 10.1161/CIRCULATIONAHA.118.033955. No abstract available.

PMID:
30012704
16.

Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).

Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL, Patton KK, Stein PK, deFilippi CR, Gottesman RF, Heckbert SR, Kronmal RA, Soliman EZ, Longstreth WT Jr.

Stroke. 2018 Apr;49(4):980-986. doi: 10.1161/STROKEAHA.117.020059. Epub 2018 Mar 13.

17.

"Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).

Peters MN, Seliger SL, Christenson RH, Hong-Zohlman SN, Daniels LB, Lima JAC, de Lemos JA, Neeland IJ, deFilippi CR.

J Am Heart Assoc. 2018 Feb 8;7(4). pii: e006619. doi: 10.1161/JAHA.117.006619.

18.

Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction.

de Boer RA, Nayor M, deFilippi CR, Enserro D, Bhambhani V, Kizer JR, Blaha MJ, Brouwers FP, Cushman M, Lima JAC, Bahrami H, van der Harst P, Wang TJ, Gansevoort RT, Fox CS, Gaggin HK, Kop WJ, Liu K, Vasan RS, Psaty BM, Lee DS, Hillege HL, Bartz TM, Benjamin EJ, Chan C, Allison M, Gardin JM, Januzzi JL Jr, Shah SJ, Levy D, Herrington DM, Larson MG, van Gilst WH, Gottdiener JS, Bertoni AG, Ho JE.

JAMA Cardiol. 2018 Mar 1;3(3):215-224. doi: 10.1001/jamacardio.2017.4987.

19.

Sedentary Behavior and Subclinical Cardiac Injury: Results From the Dallas Heart Study.

Harrington JL, Ayers C, Berry JD, Omland T, Pandey A, Seliger SL, Ballantyne CM, Kulinski J, deFilippi CR, de Lemos JA.

Circulation. 2017 Oct 10;136(15):1451-1453. doi: 10.1161/CIRCULATIONAHA.117.029493. No abstract available.

20.
21.

Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis).

Gupta DK, Daniels LB, Cheng S, deFilippi CR, Criqui MH, Maisel AS, Lima JA, Bahrami H, Greenland P, Cushman M, Tracy R, Siscovick D, Bertoni AG, Cannone V, Burnett JC, Carr JJ, Wang TJ.

Am J Cardiol. 2017 Sep 15;120(6):1008-1015. doi: 10.1016/j.amjcard.2017.06.030. Epub 2017 Jun 30.

22.

Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.

de Lemos JA, Ayers CR, Levine BD, deFilippi CR, Wang TJ, Hundley WG, Berry JD, Seliger SL, McGuire DK, Ouyang P, Drazner MH, Budoff M, Greenland P, Ballantyne CM, Khera A.

Circulation. 2017 May 30;135(22):2119-2132. doi: 10.1161/CIRCULATIONAHA.117.027272. Epub 2017 Mar 30.

23.

A Multibiomarker Approach to Heart Failure Prognostication: A Work in Progress.

deFilippi CR, Seliger SL.

JACC Heart Fail. 2017 Apr;5(4):265-267. doi: 10.1016/j.jchf.2017.02.019. No abstract available.

24.

Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department.

McCord J, Cabrera R, Lindahl B, Giannitsis E, Evans K, Nowak R, Frisoli T, Body R, Christ M, deFilippi CR, Christenson RH, Jacobsen G, Alquezar A, Panteghini M, Melki D, Plebani M, Verschuren F, French J, Bendig G, Weiser S, Mueller C; TRAPID-AMI Investigators.

Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2). pii: e003101. doi: 10.1161/CIRCOUTCOMES.116.003101.

PMID:
28167641
25.

High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).

Seliger SL, Hong SN, Christenson RH, Kronmal R, Daniels LB, Lima JAC, de Lemos JA, Bertoni A, deFilippi CR.

Circulation. 2017 Apr 18;135(16):1494-1505. doi: 10.1161/CIRCULATIONAHA.116.025505. Epub 2017 Feb 3.

26.

HIV infection, ACS, PCI and high platelet reactivity: ingredients for a perfect thrombotic storm.

Gurbel PA, deFilippi CR, Bliden KP, Tantry US.

Eur Heart J. 2017 Jun 1;38(21):1687-1689. doi: 10.1093/eurheartj/ehw630. No abstract available.

PMID:
28087604
27.

Obesity and Survival With Heart Failure: Still a Paradox.

deFilippi CR, Seliger SL.

JACC Heart Fail. 2017 Jan;5(1):64-66. doi: 10.1016/j.jchf.2016.11.011. No abstract available.

28.

Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation.

Mueller-Hennessen M, Mueller C, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Ordóñez-Llanos J, Panteghini M, Plebani M, Verschuren F, Melki D, French JK, Christenson RH, Body R, McCord J, Dinkel C, Katus HA, Lindahl B; TRAPID-AMI Investigators.

Clin Chem. 2017 Feb;63(2):542-551. doi: 10.1373/clinchem.2016.258392. Epub 2016 Dec 8.

29.

Cardiorespiratory Fitness and Highly Sensitive Cardiac Troponin Levels in a Preventive Medicine Cohort.

DeFina LF, Willis BL, Radford NB, Christenson RH, deFilippi CR, de Lemos JA.

J Am Heart Assoc. 2016 Nov 28;5(12). pii: e003781.

30.

Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease.

deFilippi CR, Herzog CA.

Clin Chem. 2017 Jan;63(1):59-65. doi: 10.1373/clinchem.2016.254748. Epub 2016 Nov 3. Review.

31.

Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study.

Brutsaert EF, Biggs ML, Delaney JA, Djoussé L, Gottdiener JS, Ix JH, Kim F, Mukamal KJ, Siscovick DS, Tracy RP, de Boer IH, deFilippi CR, Kizer JR.

Metabolism. 2016 Oct;65(10):1489-97. doi: 10.1016/j.metabol.2016.06.002. Epub 2016 Jun 24.

32.

Impact of moderate physical activity on the longitudinal trajectory of a cardiac specific biomarker of injury: Results from a randomized pilot study of exercise intervention.

deFilippi CR, de Lemos JA, Newman AB, Guralnik JM, Christenson RH, Pahor M, Church T, Espeland M, Krithevsky SB, Stafford R, Seliger SL; LIFE Study Group.

Am Heart J. 2016 Sep;179:151-6. doi: 10.1016/j.ahj.2016.07.001. Epub 2016 Jul 12.

PMID:
27595690
33.

Development and Validation of a Sudden Cardiac Death Prediction Model for the General Population.

Deo R, Norby FL, Katz R, Sotoodehnia N, Adabag S, DeFilippi CR, Kestenbaum B, Chen LY, Heckbert SR, Folsom AR, Kronmal RA, Konety S, Patton KK, Siscovick D, Shlipak MG, Alonso A.

Circulation. 2016 Sep 13;134(11):806-16. doi: 10.1161/CIRCULATIONAHA.116.023042. Epub 2016 Aug 19.

34.

Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population.

Parikh RH, Seliger SL, Christenson R, Gottdiener JS, Psaty BM, deFilippi CR.

J Am Heart Assoc. 2016 Aug 1;5(8). pii: e003188. doi: 10.1161/JAHA.115.003188.

35.

Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T - Sub-analysis from the TRAPID-AMI study.

Mueller-Hennessen M, Lindahl B, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Santalo-Bel M, Panteghini M, Plebani M, Verschuren F, Jernberg T, French JK, Christenson RH, Body R, McCord J, Dilba P, Katus HA, Mueller C; TRAPID-AMI Investigators.

Int J Cardiol. 2016 Apr 15;209:26-33. doi: 10.1016/j.ijcard.2016.01.213. Epub 2016 Feb 3.

PMID:
26878470
36.

Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).

Daniels LB, Clopton P, deFilippi CR, Sanchez OA, Bahrami H, Lima JA, Tracy RP, Siscovick D, Bertoni AG, Greenland P, Cushman M, Maisel AS, Criqui MH.

Am Heart J. 2015 Dec;170(6):1170-83. doi: 10.1016/j.ahj.2015.09.010. Epub 2015 Sep 28.

37.

Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis.

Parikh RH, Seliger SL, de Lemos J, Nambi V, Christenson R, Ayers C, Sun W, Gottdiener JS, Kuller LH, Ballantyne C, deFilippi CR.

Clin Chem. 2015 Dec;61(12):1524-31. doi: 10.1373/clinchem.2015.244160. Epub 2015 Oct 27.

38.

Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.

Beatty AL, Ku IA, Bibbins-Domingo K, Christenson RH, DeFilippi CR, Ganz P, Ix JH, Lloyd-Jones D, Omland T, Sabatine MS, Schiller NB, Shlipak MG, Skali H, Takeuchi M, Vittinghoff E, Whooley MA.

J Am Heart Assoc. 2015 Jul 6;4(7). pii: e001646. doi: 10.1161/JAHA.114.001646.

39.

Natriuretic peptide and cardiovascular risk: is it about "U"?

deFilippi CR, Seliger SL.

J Am Heart Assoc. 2015 May 21;4(5). pii: 002086. doi: 10.1161/JAHA.115.002086. No abstract available.

40.

Evolving role of galectin-3 as a cardiac biomarker: heart failure with preserved ejection fraction and renal function, important pieces of the puzzle.

deFilippi CR, Christenson RH.

JACC Heart Fail. 2015 Mar;3(3):253-6. doi: 10.1016/j.jchf.2014.12.009. No abstract available.

41.

Soluble ST2 testing in the general population.

Ho JE, Sritara P, deFilippi CR, Wang TJ.

Am J Cardiol. 2015 Apr 2;115(7 Suppl):22B-5B. doi: 10.1016/j.amjcard.2015.01.036. Epub 2015 Jan 23. Review.

PMID:
25665763
42.

Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction.

Parikh RH, Seliger SL, deFilippi CR.

Clin Biochem. 2015 Mar;48(4-5):247-53. doi: 10.1016/j.clinbiochem.2015.01.004. Epub 2015 Jan 22. Review.

PMID:
25617663
43.

High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.

Bansal N, Hyre Anderson A, Yang W, Christenson RH, deFilippi CR, Deo R, Dries DL, Go AS, He J, Kusek JW, Lash JP, Raj D, Rosas S, Wolf M, Zhang X, Shlipak MG, Feldman HI.

J Am Soc Nephrol. 2015 Apr;26(4):946-56. doi: 10.1681/ASN.2014010108. Epub 2014 Oct 2. Erratum in: J Am Soc Nephrol. 2015 Oct;26(10):2599.

44.

Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.

Glick D, deFilippi CR, Christenson R, Gottdiener JS, Seliger SL.

JACC Heart Fail. 2013 Aug;1(4):353-360. doi: 10.1016/j.jchf.2013.04.007. Epub 2013 Aug 5.

45.

Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial.

Gaggin HK, Dang PV, Do LD, deFilippi CR, Christenson RH, Lewandrowski EL, Lewandrowski KB, Truong BQ, Pham VQ, Vu VH, Vu TV, Nguyen TB, Belcher AM, Femia A, Kelley C, Januzzi JL.

Clin Chem. 2014 May;60(5):758-64. doi: 10.1373/clinchem.2013.216275. Epub 2014 Feb 25.

46.

Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).

Folsom AR, Lutsey PL, Nambi V, deFilippi CR, Heckbert SR, Cushman M, Ballantyne CM.

Vasc Med. 2014 Feb;19(1):33-41. doi: 10.1177/1358863X14520869.

47.

Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.

Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, Hoogeveen RC, Ayers CR, Sun W, McGuire DK, Ballantyne CM, de Lemos JA.

J Am Coll Cardiol. 2014 Apr 15;63(14):1441-8. doi: 10.1016/j.jacc.2013.12.032. Epub 2014 Feb 12.

48.

Cardiac biomarkers in heart failure.

Liquori ME, Christenson RH, Collinson PO, Defilippi CR.

Clin Biochem. 2014 Apr;47(6):327-37. doi: 10.1016/j.clinbiochem.2014.01.032. Epub 2014 Feb 12. Review.

PMID:
24530339
49.

Heart failure biomarkers at point-of-care: current utilization and future potential.

Christenson ES, Collinson PO, Defilippi CR, Christenson RH.

Expert Rev Mol Diagn. 2014 Mar;14(2):185-97. doi: 10.1586/14737159.2014.882772. Epub 2014 Feb 13. Review.

PMID:
24524847
50.

Fresh autologous pericardium for leaflet perforation repair in mitral valve infective endocarditis.

Evans CF, DeFilippi CR, Shang E, Griffith BP, Gammie JS.

J Heart Valve Dis. 2013 Jul;22(4):560-6.

PMID:
24224421

Supplemental Content

Loading ...
Support Center